Home » Quris and Merck KGaA extend collaboration using BioAI drug safety platform

To read the full story, subscribe or sign in.

Drug Design, Drug Delivery & Technologies

Quris and Merck KGaA extend collaboration using BioAI drug safety platform

Sep. 29, 2023

Quris Technologies Ltd. (Quris-AI) and Merck KGaA have extended their collaboration after a successful initial preclinical study of Quris-AI’s BioAI drug safety platform.

BioWorld Science Artificial intelligence Drug design, drug delivery and technologies Collaboration